ScreenIT

Latest preprint reviews

1. Sentimental Tweets Classification of Symptomatic COVID-19

   This article has 1 author:

   1. P Tharun

   Reviewed by ScreenIT

2. The Place of Fluvoxamine in the Treatment of Non-critically ill Patients with COVID-19: A Living Systematic Review and Meta-analysis

   This article has 11 authors:

   1. Salah Eddine Oussama Kacimi
   2. Elona Greca
   3. Mohamed Amine Haireche
   4. Ahmed Sallam ElHawary
   5. Mounir Ould Setti
   6. Rebecca Caruana
   7. Sahar Rizwan
   8. Hidayet Benyettou
   9. Mohammad Yasir Essar
   10. Jaffer Shah
   11. Sherief Ghozy

   Reviewed by ScreenIT

3. High-quality and easy-to-regenerate personal filter

   This article has 15 authors:

   1. Max Fraenkl
   2. Milos Krbal
   3. Jakub Houdek
   4. Zuzana Olmrova Zmrhalova
   5. Borivoj Prokes
   6. Petr Hejda
   7. Stanislav Slang
   8. Jan Prikryl
   9. Jakub Ondracek
   10. Otakar Makes
   11. Juraj Kostyk
   12. Petr Nasadil
   13. Pavel Malcik
   14. Vladimir Zdimal
   15. Miroslav Vlcek

   Reviewed by ScreenIT

4. SARS-CoV-2 vaccine effectiveness and breakthrough infections in maintenance dialysis patients

   This article has 8 authors:

   1. Harold J. Manley
   2. Gideon N. Aweh
   3. Caroline M. Hsu
   4. Daniel E. Weiner
   5. Dana Miskulin
   6. Antonia M. Harford
   7. Doug Johnson
   8. Eduardo K. Lacson

   Reviewed by ScreenIT

5. Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022

   This article has 11 authors:

   1. Dirk Eggink
   2. Stijn P Andeweg
   3. Harry Vennema
   4. Noortje van Maarseveen
   5. Klaas Vermaas
   6. Boris Vlaemynck
   7. Raf Schepers
   8. Arianne B van Gageldonk-Lafeber
   9. Susan van den Hof
   10. Chantal BEM Reusken
   11. Mirjam J Knol

   Reviewed by ScreenIT

6. Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma

   This article has 58 authors:

   1. David J. Sullivan
   2. Kelly A. Gebo
   3. Shmuel Shoham
   4. Evan M. Bloch
   5. Bryan Lau
   6. Aarthi G. Shenoy
   7. Giselle S. Mosnaim
   8. Thomas J. Gniadek
   9. Yuriko Fukuta
   10. Bela Patel
   11. Sonya L. Heath
   12. Adam C. Levine
   13. Barry R. Meisenberg
   14. Emily S. Spivak
   15. Shweta Anjan
   16. Moises A. Huaman
   17. Janis E. Blair
   18. Judith S. Currier
   19. James H. Paxton
   20. Jonathan M. Gerber
   21. Joann R. Petrini
   22. Patrick B. Broderick
   23. William Rausch
   24. Marie Elena Cordisco
   25. Jean Hammel
   26. Benjamin Greenblatt
   27. Valerie C. Cluzet
   28. Daniel Cruser
   29. Kevin Oei
   30. Matthew Abinante
   31. Laura L. Hammitt
   32. Catherine G. Sutcliffe
   33. Donald N. Forthal
   34. Martin S. Zand
   35. Edward R. Cachay
   36. Jay S. Raval
   37. Seble G. Kassaye
   38. E. Colin Foster
   39. Michael Roth
   40. Christi E. Marshall
   41. Anusha Yarava
   42. Karen Lane
   43. Nichol A. McBee
   44. Amy L. Gawad
   45. Nicky Karlen
   46. Atika Singh
   47. Daniel E. Ford
   48. Douglas A. Jabs
   49. Lawrence J. Appel
   50. David M. Shade
   51. Stephan Ehrhardt
   52. Sheriza N. Baksh
   53. Oliver Laeyendecker
   54. Andrew Pekosz
   55. Sabra L. Klein
   56. Arturo Casadevall
   57. Aaron A.R. Tobian
   58. Daniel F. Hanley

   Reviewed by ScreenIT

7. Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles

   This article has 21 authors:

   1. Abdullah M. Syed
   2. Alison Ciling
   3. Taha Y. Taha
   4. Irene P. Chen
   5. Mir M. Khalid
   6. Bharath Sreekumar
   7. Pei-Yi Chen
   8. G. Renuka Kumar
   9. Rahul Suryawanshi
   10. Ines Silva
   11. Bilal Milbes
   12. Noah Kojima
   13. Victoria Hess
   14. Maria Shacreaw
   15. Lauren Lopez
   16. Matthew Brobeck
   17. Fred Turner
   18. Lee Spraggon
   19. Takako Tabata
   20. Melanie Ott
   21. Jennifer A. Doudna

   Reviewed by ScreenIT

8. Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab

   This article has 14 authors:

   1. Natacha Madelon
   2. Nelli Heikkilä
   3. Irène Sabater Royo
   4. Paola Fontannaz
   5. Gautier Breville
   6. Kim Lauper
   7. Rachel Goldstein
   8. Alba Grifoni
   9. Alessandro Sette
   10. Claire-Anne Siegrist
   11. Axel Finckh
   12. Patrice H. Lalive
   13. Arnaud M. Didierlaurent
   14. Christiane S. Eberhardt

   Reviewed by ScreenIT

9. Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose

   This article has 16 authors:

   1. Yaniv Lustig
   2. Tal Gonen
   3. Lilac Meltzer
   4. Mayan Gilboa
   5. Victoria Indenbaum
   6. Carmit Cohen
   7. Sharon Amit
   8. Hanaa Jaber
   9. Ram Doolman
   10. Keren Asraf
   11. Carmit Rubin
   12. Ronen Fluss
   13. Ella Mendelson
   14. Laurence Freedman
   15. Gili Regev-Yochay
   16. Yitshak Kreiss

   Reviewed by ScreenIT

10. Comparative effectiveness of the BNT162b2 and ChAdOx1 vaccines against Covid-19 in people over 50

    This article has 6 authors:

    1. Junqing Xie
    2. Shuo Feng
    3. Xintong Li
    4. Ester Gea-Mallorquí
    5. Albert Prats-Uribe
    6. Dani Prieto-Alhambra

    Reviewed by ScreenIT